SPDR S&P Biotech ETF $XBI Shares Acquired by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 42,425.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,190,707 shares of the exchange traded fund’s stock after buying an additional 1,187,907 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in SPDR S&P Biotech ETF were worth $145,147,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. raised its holdings in SPDR S&P Biotech ETF by 868.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after purchasing an additional 4,411 shares in the last quarter. Banque Pictet & Cie SA grew its position in shares of SPDR S&P Biotech ETF by 24.1% in the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after purchasing an additional 12,595 shares during the last quarter. Apella Capital LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $490,000. PNC Financial Services Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 60.9% in the third quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock valued at $7,067,000 after purchasing an additional 26,705 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in SPDR S&P Biotech ETF by 106.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after acquiring an additional 13,729 shares during the period.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $136.40 on Tuesday. The stock has a market capitalization of $8.70 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $139.19. The company has a 50 day moving average price of $132.78 and a two-hundred day moving average price of $127.28.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.